VERA
Vera Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$36.99-3.92%
Price as of Jul 20, 2026
VERA growth
Vera Therapeutics, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- —
- EBIT
- -98.4%
- EPS
- -77.0%
- Free cash flow
- -62.1%
- Operating cash flow
- -88.8%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +14.3%
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- -88.7%
- Net income
- -96.9%
- EPS
- -69.5%
- Free cash flow
- -78.2%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.